Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 610846, 9 pages
http://dx.doi.org/10.1155/2015/610846
Research Article

Postmarketing Safety Surveillance and Reevaluation of Danhong Injection: Clinical Study of 30888 Cases

1The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, China
2Shandong Buchang Pharmaceutical Co., Ltd., Heze 274000, China

Received 12 November 2014; Revised 24 February 2015; Accepted 10 March 2015

Academic Editor: Cheryl Hawk

Copyright © 2015 Xue-Lin Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Pharmacopoeia Committee, Chinese Pharmacopoeia, Part 1, Appendix 13, Chemical Industry Press, Beijing, China, 2005.
  2. Y.-Y. Xie, X. Xiao, J.-M. Luo et al., “Integrating qualitative and quantitative characterization of traditional Chinese medicine injection by high-performance liquid chromatography with diode array detection and tandem mass spectrometry,” Journal of Separation Science, vol. 37, no. 12, pp. 1438–1447, 2014. View at Publisher · View at Google Scholar
  3. D.-Q. Ren and B.-L. Zhang, Clinical Application Guide of TCM Injections, People's Health Publishing House, Beijing, China, 2011.
  4. W.-T. Song, F.-F. Cheng, L. Xu, C.-R. Lin, and J.-X. Liu, “Chinese medicine shenfu injection for heart failure: a systematic review and meta-analysis,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 713149, 25 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Sun, J.-J. Zhang, J.-Z. Shan et al., “Clinical observation of Danhong Injection (herbal TCM product from Radix Salviae miltiorrhizae and Flos Carthami tinctorii) in the treatment of traumatic intracranial hematoma,” Phytomedicine, vol. 16, no. 8, pp. 683–689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Zhao, H. Fan, T. Higgins et al., “Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways,” Cancer Letters, vol. 355, no. 2, pp. 232–241, 2014. View at Publisher · View at Google Scholar
  7. X.-J. Niu, “The situation, causes, and prevention of adverse reactions of traditional Chinese medicine injections,” Chinese Journal of Clinical Rational Drug Use, vol. 7, no. 7, pp. 93–94, 2014. View at Google Scholar
  8. A. Miguel, L. F. Azevedo, M. Araújo, and A.-C. Pereira, “Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis,” Pharmacoepidemiology and Drug Safety, vol. 21, no. 11, pp. 1139–1154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. K. J. Patel, M. S. Kedia, D. Bajpai, S. S. Mehta, N. A. Kshirsagar, and N. J. Gogtay, “Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study,” BMC Clinical Pharmacology, vol. 7, article 8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Guan, Y. Yin, Y.-R. Zhu et al., “Dissection of mechanisms of a Chinese medicinal formula: danhong injection therapy for myocardial ischemia/reperfusion injury in vivo and in vitro,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 972370, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S.-J. Li, Y.-P. Tang, J. Shen, J.-P. Li, J.-M. Guo, and J.-A. Duan, “Research of Chinese medicine pairs (VIII)-salviae miltiorrhizae radix et rhizoma-carthami Flos,” Chian Journal of Chinese Materia Medica, vol. 38, no. 24, pp. 4227–4231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Shi, Y. Zhao, S.-W. Zheng, and P. Huang, “Analysis of clinical use of the post-marketing Danhong injection based on hospital central monitoring method information system,” Chinese Journal of Hospital Pharmacy, vol. 34, no. 2, pp. 119–122, 2014. View at Google Scholar
  13. L.-M. Huang, J.-Q. Ma, X. Zhang, -L. Kang, S.-C. Zhang, and S.-H. Zhang, “Use situation of Danhong injection: centralized monitoring of 987 cases,” China Pharmaceuticals, vol. 22, no. 17, pp. 49–50, 2013. View at Google Scholar
  14. S. Yu and Y.-X. Liu, “The clinical efficacy of Danhong injection in treating angina pectoris,” Guide of China Medicine, vol. 10, no. 11, pp. 47–48, 2012. View at Google Scholar
  15. X. Li, J. Tang, F. Meng, C. Li, and Y. Xie, “Comparative study on four kinds of assessment methods of post-marketing safety of Danhong injection,” China Journal of Chinese Materials Medica, vol. 36, no. 20, pp. 2786–2788, 2011. View at Google Scholar · View at Scopus
  16. D.-Q. Ren and B.-L. Zhang, Guide for Clinical Application of Traditional Chinese Medicine Injections, People's Medical Publishing House, Beijing, China, 2011.
  17. Y.-Y. Wang, A.-P. Lv, and Y.-M. Xie, The Key Technologies of Clinical Re-evaluation of Post-Marketing Traditional Chinese Medicine, People's Medical Publishing House, Beijing, China, 2011.
  18. E.-W. Baars, M. Jong, A.-F. Nierop, I. Boers, and H.-F. Savelkoul, “Citrus/cydonia compositum subcutaneous injections versus nasal spray for seasonal allergic rhinitis: a randomized controlled trial on efficacy and safety,” ISRN Allergy, vol. 2011, Article ID 836051, 11 pages, 2011. View at Publisher · View at Google Scholar
  19. International Drug Monitoring, The Role of the Hospital, vol. 425 of World Health Organization Technical Report Series, 1969.
  20. K.-C. Pearson and D.-L. Kennedy, “Adverse drug reactions and the food and drug administration,” Journal of Pharmacy Practice, vol. 2, no. 4, pp. 209–213, 1989. View at Publisher · View at Google Scholar
  21. Joint Commission on Accreditation of Healthcare Organizations, Accreditation Manual for Hospitals, Joint Commission on Accreditation of Healthcare Organizations, Chicago, Ill, USA, 1991.
  22. W. Lu, P. Jiang, and S.-H. Zhang, “Post-marketing safety re-evaluation of Shenmai injection,” China Journal of Hospital Pharmacy, vol. 33, no. 6, pp. 491–492, 2013. View at Google Scholar
  23. Q.-H. Ai, W. Zhang, Y.-M. Xie, W.-H. Huang, H. Liang, and H. Cao, “Post-marketing safety monitoring of Shenqifuzheng injection: a solution made of Dangshen (Radix Codonopsis) and Huangqi (Radix Astragali Mongolici),” Journal of Traditional Chinese Medicine, vol. 34, no. 4, pp. 498–503, 2014. View at Google Scholar
  24. T. Harris, K. Wong, L. Stanford, J. Fediurek, N. Crowcroft, and S.-L. Deeks, “Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada? A review of post-marketing safety surveillance data,” Eurosurveillance, vol. 19, no. 36, 2014. View at Publisher · View at Google Scholar